Homology Medicines Inc.

Homology Medicines Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Homology Medicines Inc. is not a good value stock. Homology Medicines Inc. is not a good growth stock. Homology Medicines Inc. is not very popular among insiders. Homology Medicines Inc. is a mediocre stock to choose.
Log in to see more information.
Homology Medicines, Inc. operates as a technology platform to design and develop treatments to addre...
FIXX Fundamental Data by TradingView

News

Homology Medicines (NASDAQ:FIXX) Trading Down 0.7%
Homology Medicines (NASDAQ:FIXX) Trading Down 0.7%

Ticker Report Homology Medicines, Inc. (NASDAQ:FIXX Get Free Report)s share price was down 0.7% during trading on Thursday . The stock traded as low as $0.68 and last traded at $0.71. Approximately...\n more…

Homology Medicines (NASDAQ:FIXX) & GeoVax Labs (NASDAQ:GOVXW) Head-To-Head Contrast
Homology Medicines (NASDAQ:FIXX) & GeoVax Labs (NASDAQ:GOVXW) Head-To-Head Contrast

Ticker Report Homology Medicines (NASDAQ:FIXX Get Free Report) and GeoVax Labs (NASDAQ:GOVXW Get Free Report) are both medical companies, but which is the superior investment? We will contrast the...\n more…

Homology Medicines gets non-compliance notice from Nasdaq
Homology Medicines gets non-compliance notice from Nasdaq

SeekingAlpha.com: All News Homology Medicines receives notification from Nasdaq regarding minimum bid price deficiency.\n more…

Homology Medicines receives noncompliance notification from Nasdaq
Homology Medicines receives noncompliance notification from Nasdaq

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency
Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency

Globe Newswire Homology Medicines has an initial 180-day period through June 26, 2024 to regain compliance with Minimum Bid Price Requirement BEDFORD, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Homology...\n more…

Short Interest in Homology Medicines, Inc. (NASDAQ:FIXX) Rises By 48.9%
Short Interest in Homology Medicines, Inc. (NASDAQ:FIXX) Rises By 48.9%

Zolmax Homology Medicines, Inc. (NASDAQ:FIXX Get Free Report) was the recipient of a significant increase in short interest in November. As of November 30th, there was short interest totalling...\n more…